GoodRx Holdings announced that CFO Christopher McGinnis will transition out of his role effective August 5, 2026. The Board appointed current Chief Strategy & Operations Officer Justin Fengler as the new CFO and Treasurer, effective August 6, 2026. Fengler received a $1 million equity grant (RSU and PSU awards) and a $100,000 one-time cash payment upon appointment. McGinnis is eligible for severance under the Executive Severance Plan. GoodRx Holdings operates in the digital health industry, providing prescription drug discount coupons and price transparency tools.